MEDICINES CO's ticker is and the CUSIP is 584688AE5. A total of 39 filers reported holding MEDICINES CO in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,102,000 | +73.8% | 10,000,000 | +42.9% | 0.61% | -3.2% |
| Q1 2019 | $6,964,000 | +13.9% | 7,000,000 | 0.0% | 0.63% | -51.9% |
| Q4 2018 | $6,112,000 | -66.5% | 7,000,000 | -53.3% | 1.30% | -48.6% |
| Q2 2018 | $18,240,000 | +5.4% | 15,000,000 | 0.0% | 2.53% | +63.6% |
| Q1 2018 | $17,301,000 | -45.5% | 15,000,000 | -50.0% | 1.55% | -50.6% |
| Q4 2017 | $31,721,000 | +25.5% | 30,000,000 | +50.0% | 3.13% | +27.5% |
| Q3 2017 | $25,268,000 | +29.4% | 20,000,000 | +33.3% | 2.46% | +80.2% |
| Q2 2017 | $19,520,000 | -1.2% | 15,000,000 | +20.0% | 1.36% | -7.1% |
| Q1 2017 | $19,763,000 | -40.2% | 12,500,000 | -54.5% | 1.47% | -36.0% |
| Q4 2016 | $33,069,000 | +104.4% | 27,500,000 | +120.0% | 2.29% | +122.9% |
| Q3 2016 | $16,175,000 | -46.4% | 12,500,000 | -51.0% | 1.03% | -60.7% |
| Q2 2016 | $30,177,000 | -11.2% | 25,500,000 | -15.0% | 2.62% | -19.9% |
| Q1 2016 | $33,984,000 | – | 30,000,000 | – | 3.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 3,588,000 | $4,370,000 | 3.61% |
| Cheyne Capital Management (UK) LLP | 3,000,000 | $3,654,000 | 2.60% |
| Myriad Asset Management Ltd. | 15,000,000 | $18,240,000 | 2.53% |
| DLD Asset Management, LP | 22,500,000 | $27,506,000 | 2.07% |
| SILVERBACK ASSET MANAGEMENT LLC | 11,000,000 | $13,379,000 | 1.70% |
| BASSO CAPITAL MANAGEMENT, L.P. | 3,841,000 | $4,662,000 | 0.89% |
| TFG Asset Management GP Ltd | 5,000,000 | $6,148,000 | 0.84% |
| WOLVERINE ASSET MANAGEMENT LLC | 51,660,000 | $62,769,000 | 0.81% |
| Weiss Asset Management LP | 5,000,000 | $6,142,000 | 0.61% |
| City Financial Investment Co Ltd | 7,500,000 | $9,073,000 | 0.46% |